A Study of IMR-687 in Adult Patients With Sickle Cell Anaemia (Homozygous HbSS or Sickle- β0 Thalassemia)

Condition:   Sickle Cell Disease Intervention:   Drug: IMR-687 Sponsor:   Imara, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials